Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer.
Dings MPG, Manoukian P, Waasdorp C, Quik JSE, Strijker M, Lodestijn SC, van Neerven SM, Moreno LF, de Oliveira RL, Bonsing BA, Bruno MJ, Busch OR, Doukas M, van Eijck CH, Mohammad NH, de Hingh IH, Molenaar QI, Besselink MG, Vermeulen L, Medema JP, van Laarhoven HWM, Bijlsma MF.
Dings MPG, et al. Among authors: vermeulen l.
Int J Cancer. 2023 Feb 1;152(3):511-523. doi: 10.1002/ijc.34276. Epub 2022 Sep 19.
Int J Cancer. 2023.
PMID: 36069222
Free PMC article.